-
Product Insights
NewPT Bumi Resources Bengalon Complex, Indonesia
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Product Insights
NewPT Pupuk Kaltim Fakfak Complex, Indonesia
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Product Insights
NewPT Chandra Asri Cilegon Complex, Indonesia
Each petrochemical complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We also provide contractor details such as EPC/Design & FEED contractors for the petrochemical complex. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day...
-
Product Insights
PT Pertamina Balongan Complex, Indonesia
PT Pertamina Balongan Complex is located in West Java, Indonesia. The petrochemicals complex is owned by PT Pertamina (Persero). It is operated by PT Pertamina (Persero). The project started its operations in 2013. PT Pertamina Balongan Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual capacity of the complex. We...
-
Product Insights
PT Pupuk Sriwidjaja Palembang Complex, Indonesia
PT Pupuk Sriwidjaja Palembang Complex is located in South Sumatra, Indonesia. The petrochemicals complex is owned by PT Pupuk Indonesia Holding Co. It is operated by PT Pupuk Sriwidjaja Palembang. The project started its operations in 1994. PT Pupuk Sriwidjaja Palembang Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual...
-
Product Insights
PT Asahimas Chemical Cilegon Complex, Indonesia
PT Asahimas Chemical Cilegon Complex is located in Banten, Indonesia. The petrochemicals complex is owned by Mitsubishi Corp (11.50%); AGC Inc (52.50%); Others (18%); PT Rodamas (18.00. It is operated by PT Asahimas Chemical. The project started its operations in 1989. PT Asahimas Chemical Cilegon Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share...
-
Product Insights
PT Pupuk Kaltim Bontang Complex, Indonesia
PT Pupuk Kaltim Bontang Complex is located in South Sulawesi, Indonesia. The petrochemicals complex is owned by PT Pupuk Indonesia Holding Co. It is operated by PT Pupuk Kalimantan Timur. The project started its operations in 1989. PT Pupuk Kaltim Bontang Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products produced, operator, technology, key products capacity and capacity share of the total annual...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-009 in Asthma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PT-009 in Asthma Drug Details:PT-009 is under development for the treatment of moderate to severe chronic...
-
Product Insights
PT Pupuk Indonesia Teluk Bintuni Complex, Indonesia
PT Pupuk Indonesia Teluk Bintuni Complex is located in West Papua, Indonesia. The petrochemicals complex is owned by PT Pupuk Indonesia Holding Co. It will be operated by PT Pupuk Indonesia Holding Co. The project is currently in the announced stage and is expected to start operations in 2026. PT Pupuk Indonesia Teluk Bintuni Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key feedstock, key products...
-
Company Profile
![]()
PT Unilever Indonesia Tbk – Company Profile
PT Unilever Indonesia Tbk (Unilever Indonesia), a subsidiary of Unilever Plc, is a provider of consumer products. The company's product portfolio comprises food and non-food items including soy sauce, cosmetic products, soaps, detergents, ice cream, savory products, tea-based beverages, and fruit juice. It also provides a range of body care, oral care, skincare, nutrition, home care, and personal care products. The company markets these products under some of the world-renowned brands including Pepsodent, Lux, Dove, Pond's, Glow & Lovely, Axe,...
Add to Basket -
Company Profile
![]()
PT Gudang Garam Tbk – Company Profile
PT Gudang Garam Tbk (Gudang Garam) is a manufacturer and marketer of tobacco products. The company offers handmade, machine made and low-tar, low nicotine cigarettes. Its cigarettes are marketed under Klobot, Sriwedari, Djaja, Patra, Surya series, Merah, GG Mild, GG Signature, Sriwedari, GG Mild Shiver and GG Move brand names. The company manufactures paperboards for packaging and offers entertainment and media development, and air transport services. It operates representative offices in Jakarta and production plants in Indonesia in Kediri and...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-217 in Prostate Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-217 in Prostate Cancer Drug Details: PT-217 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-217 in Neuroendocrine Cancer
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-217 in Neuroendocrine Cancer Drug Details: PT-217 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Alcohol Addiction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Alcohol Addiction Drug Details: PT-150 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-886 in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PT-886 in Gastric Cancer Drug Details:PT-886 is under development for the treatment of metastatic gastric adenocarcinoma, ...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-199 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-199 in Solid Tumor Drug Details: PT-199 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-01 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PT-01 in Solid Tumor Drug Details:PT-01 (Pegtomarginase) is under development for the treatment of solid malignancies...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-01 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PT-01 in Metastatic Melanoma Drug Details:PT-01 (Pegtomarginase) is under development for the treatment of solid malignancies...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-150 in Smoking Cessation
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. PT-150 in Smoking Cessation Drug Details: PT-150 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PT-101 in Ulcerative Colitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PT-101 in Ulcerative ColitisDrug Details:PT-101 is under development for the treatment of ulcerative colitis, systemic lupus...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.